Clinical Trial: Plasma Exeresis Plus NB-UVB Versus NB-UVB Alone for Stable Vitiligo

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907744) titled 'Plasma Exeresis Plus NB-UVB Versus NB-UVB Alone for Stable Vitiligo' on Oct. 25.

Brief Summary: The goal of this quasi-experimental clinical trial is to compare the effectiveness of plasma exeresis combined with narrowband ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in patients with stable non-segmental vitiligo aged 8 to 65 years.

The main questions it aims to answer are:

* Does plasma exeresis combined with NB-UVB produce greater repigmentation than NB-UVB alone after 24 weeks?

* Is combination therapy associated with better clinical response as measured by the Vitiligo Area Scoring Index (VASI)?

Researchers ...